Print Magazine
Brussels Morning Newspaper
Tuesday, September 26, 2023
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home EU Institutions

EC sues AstraZeneca over vaccine delivery delays

Ivan Fischer by Ivan Fischer
27 April 2021
in EU Institutions
EC sues AstraZeneca over vaccine delivery delays
Share on FacebookShare on Twitter

Brussels (Brussels Morning) The European Union launched legal action on Monday against British-Swedish pharmaceuticals giant AstraZeneca for its persistent delays and shortfalls in delivering the coronavirus vaccines ordered by the bloc, France24 reported.

“The Commission has started last Friday a legal action against the company AstraZeneca on the basis of breaches of the advanced purchase agreement”, European Commission spokesman Stefan De Keersmaecker said, clarifying that the lawsuit had been raised on behalf of all 27 EU member states.

Failure to observe terms

According to the Commission, member states are suing AstraZeneca for its reported failure to respect and observe the terms of the contract for the supply of vaccine doses, and for not having a “reliable plan” to ensure timely deliveries.

The company, on the other hand, claims the lawsuit has no merit and plans to defend itself in court. “AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court”, a company statement declared. “We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible”.

Delivery delays

The delivery delays of the vaccine have seriously contributed to the problems the EU has experienced in its vaccination drive, since the Commission counted on the AstraZeneca vaccine as key to its plans to vaccinate the majority of the bloc’s citizens. Faced with repeated delivery cuts, the Commission has turned away from AstraZeneca, deciding not to pursue its option to order more doses from the company and instead has started to rely more on Pfizer’s shots.
“Some terms of the contract have not been respected and the company has not been in a position to come up with a reliable strategy to ensure timely delivery of doses”, the EC spokesman said. “We want to make sure there is a speedy delivery of a sufficient number of doses that European citizens are entitled to and which have been promised on the basis of the contract”.

Tags: Main-Slider
Follow Brussels Morning
Facebook Twitter Youtube Linkedin

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

More Info

  • About Us
  • Advertising
  • Cookie Policy
  • Contact Us
  • FAQ
  • Jobs

Categories

  • Belgium News
  • Brussels
  • Culture and Society
  • Economy
  • EU Institutions
  • Commission
  • Council
  • Parliament
  • Europe
  • Features
  • Health & Fitness
  • In Depth
  • Ambassador’s Corner
  • Europe With Transparency
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Member States
  • Opinion
  • Our pick
  • Uncategorised
  • World
  • Diplomacy
  • Middle East Eye
  • US Elections
  • Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2020

    No Result
    View All Result
    • Home
    • About Us
    • Brussels Bubble
      • Parliament
      • Commission
      • Council
    • Wider Europe
      • Member States
    • World
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT